ABI793 is a human IgG1 anti-CD154 (CD40 ligand) monoclonal antibody. It inhibits immune responses by blocking the CD154-CD40 (IC50= 75 nM) signaling pathway. ABI793 is effective in preventing kidney transplant rejection and can be used in research related to immune rejection responses.
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted